Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children

European Journal of Pediatrics

Volumn 172, Issue 3, 2013, Pages 337-342

  Gámez González, Luisa Berenise ^a   Murata, Chiharu ^a   Muñoz Ramírez, Mireya ^a   Yamazaki Nakashimada, Marco ^a  

^a INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

Author keywords

Gastrointestinal involvement; IVIG resistance; Kawasaki disease; Shock

Indexed keywords

ADRENALIN; DOBUTAMINE; IMMUNOGLOBULIN; MILRINONE; NORADRENALIN;

ARTICLE; ARTIFICIAL VENTILATION; CARDIOGENIC SHOCK; CHILD; CORONARY ARTERY ANEURYSM; DISEASE ASSOCIATION; FEMALE; FLUID RESUSCITATION; HEART INFARCTION; HUMAN; INFANT; INOTROPISM; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEPTIC SHOCK; SHOCK;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INTENSIVE CARE; MALE; MEXICO; MUCOCUTANEOUS LYMPH NODE SYNDROME; PREVALENCE; SEVERITY OF ILLNESS INDEX; SHOCK; TREATMENT OUTCOME;

EID: 84877149718     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-012-1879-1     Document Type: Article

References (19)

1. Belay ED, Maddox RA, Holman RC, Curns AT, Ballah K, Schonberger LB (2006) Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003. Pediatr Infect Dis J 25:245. doi: 10.1097/01.inf.0000202068. 30956.16
2. Bosland A, Arlaud K, Rousset-Rouviere C, Fouilloux V, Paut O, Dubus JC, Bosdure E (2008) Streptococcal toxic shock syndrome or Kawasaki disease? Two cases studies of children with group A streptococcal pneumonia empyema. Arch Pediatr 18:1310-1314. doi: 10.1016/j.arcped.2011.09.027
3. Chahal N, Somji Z, Manhiot C, Clarizia NA, Ashley J, Yeung RS, McCrindle BW (2012) Rate, associated factors and outcomes of recurrence of Kawasaki disease in Ontario, Canada. Pediatr Int 54:383-387. doi: 10.1111/j.1442-200X. 2012.03628.x
4. Davies HD, Kirk V, Jadavji T, Kotzin BL (1996) Simultaneous presentation of Kawasaki disease and toxic shock syndrome in an adolescent male. Pediatr Infect Dis J 15:1136-1138
5. Dominguez SR, Friedman K, Seewald R, Anderson MS, Willis L, Glode ML (2008) Kawasaki disease in a pediatric intensive care unit: a case-control study. Pediatrics 122:786-790. doi: 10.1542/peds.2008-1275
6. Gatterre P, Oualha M, Dupic L, Iserin F, Bodemer C, Lesage F, Hubert P (2012) Kawasaki disease: an unexpected etiology of shock and multiple organ dysfunction syndrome. Intensive Care Med 38:872-878. doi: 10.1007/s00134-012- 2473-8
7. Gomez-Moyano E, Vera Casaño A, Camacho J, Sanz Trelles A, Crespo-Erchiga V (2011) Kawasaki disease complicated by cutaneous vasculitis and peripheral gangrene. J Am Acad Derm 64:e74-e75. doi: 10.1016/j.jaad.2010.04.029
8. Kanegaye JT, Wilder MS, Molkara D, Frazer JR, Pancheri J, Tremoulet AH, Watson VE, Best BM, Burns JC (2009) Recognition of a Kawasaki disease shock syndrome. Pediatrics 123:e783-e789. doi: 10.1542/peds.2008-1871
9. Kato H, Koike S, Yamamoto M, Ito Y, Yano E (1975) Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. J Pediatr 86:892-898
10. Matsubara K, Fukaya T (2007) The role of superantigens of group-a Streptococcus and Staphylococcus aureus in Kawasaki disease. Curr Opin Infect Dis 20:298-303. doi: 10.1097/QCO.0b013e3280964d8c
11. Nagata S, Yamashiro Y, Ohtsuka Y, Shimizu T, Sakurai Y, Misawa S, Ito T (2009) Heat shock proteins and superantigenic properties of bacteria from the gastrointestinal tract of patients with Kawasaki disease. Immunology 128:511-520. doi: 10.1111/j.1365-2567.2009.03135.x
12. Natterer J, Perez MH, Di Bernardo S (2011) Capillary leak leading to shock in Kawasaki disease without myocardial dysfunction. Cardiol Young 21:1-4. doi: 10.1017/S1047951111001314
13. Newburger JW, Sleeper LA, McCrindle BW, Minich LL, Gersony W, Vetter VL, Atz AM, Li JS, Takahashi M, Baker AL, Colan SD, Mitchell PD, Klein GL, Sundel RP, Pediatric Heart Network Investigators (2007) Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. New Engl J Med 356:663-675. doi: 10.1056/NEJMoa061235
14. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110:2747-2771. doi: 10. 1161/0.1. CIR. 0000145143.19711.78
15. Singh R, Ward C, Walton M, Persad R (2007) Atypical Kawasaki disease and gastrointestinal manifestations. Paediatr Child Health 12:235-237
16. Suenaga T, Suzuki H, Shibuta S, Takeuchi T, Yoshikawa N (2009) Detection of multiple superantigen genes in stools of patients with Kawasaki disease. J Pediatr 155:266-270. doi: 10.1016/j.jpeds.2009.03.013
17. Thabet F, Bafaqih H, Al-Mohaimeed S, Al-Hilali M, Al-Sewari W, Chehab M (2011) Shock: an unusual presentation of Kawasaki disease. Eur J Pediatr 170:941-943. doi: 10.1007/s00431-011-1426-5
18. Wang W, Zhu WH, Qi YQ, Fu SL, Gong FQ (2012) Cardiogenic shock: do not forget the possibility of Kawasaki disease. Turk J Pediatr 54:86-89
19. Zulian F, Falcini F, Zancan L, Martini G, Seccheri S, Luzzatto C, Zacchello F (2003) Acute surgical abdomen as presenting manifestation of Kawasaki disease. J Pediatr 142:731-735. doi: 10.1067/mpd.2003.232